Invention Grant
- Patent Title: Dosing preparation of dabigatran etexilate or a salt thereof and a preparation method thereof
-
Application No.: US15308014Application Date: 2015-10-08
-
Publication No.: US10675276B2Publication Date: 2020-06-09
- Inventor: Xiaoxia Sheng , Yong Tang
- Applicant: Hangzhou SoliPharma Co., Ltd.
- Applicant Address: CN Hangzhou
- Assignee: HANGZHOU SOLIPHARMA CO., LTD.
- Current Assignee: HANGZHOU SOLIPHARMA CO., LTD.
- Current Assignee Address: CN Hangzhou
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@32dd8283
- International Application: PCT/CN2015/091437 WO 20151008
- International Announcement: WO2016/070696 WO 20160512
- Main IPC: A61K31/4439
- IPC: A61K31/4439 ; A61K9/00 ; A61K9/50 ; A61K9/48
Abstract:
The present invention relates to two novel oral pharmaceutical compositions of dabigatran etexilate or its pharmaceutically acceptable salts thereof, and the processes of preparation thereof.
Public/Granted literature
- US20170049764A1 Dosing Preparation of Dabigatran Etexilate or a Salt Thereof and a Preparation Method Thereof Public/Granted day:2017-02-23
Information query
IPC分类:
